Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.53 - $0.93 $3.03 Million - $5.31 Million
-5,711,827 Reduced 68.14%
2,671,124 $1.55 Million
Q4 2023

Feb 14, 2024

BUY
$0.63 - $1.14 $5.26 Million - $9.51 Million
8,341,503 Added 20125.22%
8,382,951 $6.96 Million
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $2.07 Million - $3.22 Million
-1,580,746 Reduced 97.44%
41,448 $66,000
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $2.22 Million - $4.51 Million
1,530,127 Added 1661.97%
1,622,194 $2.47 Million
Q4 2022

Feb 14, 2023

SELL
$2.02 - $3.25 $322,343 - $518,622
-159,576 Reduced 63.41%
92,067 $221,000
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.14 $4.53 Million - $7.26 Million
-2,310,821 Reduced 90.18%
251,643 $516,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $4.12 Million - $8.37 Million
-3,169,562 Reduced 55.3%
2,562,464 $4.97 Million
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $1.9 Million - $2.81 Million
810,497 Added 16.47%
5,732,026 $14.1 Million
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $2.54 Million - $4.99 Million
-869,925 Reduced 15.02%
4,921,529 $15.8 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $771,277 - $1.03 Million
154,875 Added 2.75%
5,791,454 $30.4 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $3.97 Million - $8.51 Million
1,549,205 Added 37.9%
5,636,579 $30.9 Million
Q1 2021

May 17, 2021

SELL
$2.69 - $5.25 $823,742 - $1.61 Million
-306,224 Reduced 6.97%
4,087,374 $11.1 Million
Q4 2020

Feb 16, 2021

BUY
$3.17 - $4.49 $6.34 Million - $8.98 Million
1,999,799 Added 83.54%
4,393,598 $14 Million
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $162,857 - $284,180
54,650 Added 2.34%
2,393,799 $9.58 Million
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $5.36 Million - $9.92 Million
2,339,149 New
2,339,149 $9.19 Million
Q1 2020

May 14, 2020

SELL
$1.92 - $4.39 $1.38 Million - $3.15 Million
-717,360 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$2.41 - $4.4 $79,836 - $145,758
-33,127 Reduced 4.41%
717,360 $2.92 Million
Q3 2019

Nov 14, 2019

SELL
$2.17 - $3.14 $1.13 Million - $1.64 Million
-521,516 Reduced 41.0%
750,487 $1.94 Million
Q2 2019

Aug 15, 2019

BUY
$2.53 - $3.04 $2.09 Million - $2.52 Million
827,323 Added 186.05%
1,272,003 $3.82 Million
Q2 2019

Aug 14, 2019

SELL
$2.53 - $3.04 $380,648 - $457,380
-150,454 Reduced 25.28%
444,680 $38.8 Million
Q1 2019

May 14, 2019

SELL
$2.51 - $3.73 $1.07 Million - $1.59 Million
-426,253 Reduced 41.73%
595,134 $1.77 Million
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $601,568 - $1.01 Million
378,345 Added 58.84%
1,021,387 $2.43 Million
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $870,294 - $1.32 Million
547,355 Added 572.03%
643,042 $1.38 Million
Q2 2018

Aug 14, 2018

SELL
$2.26 - $4.65 $1.92 Million - $3.96 Million
-851,105 Reduced 89.89%
95,687 $217,000
Q1 2018

May 15, 2018

SELL
$3.51 - $6.04 $5.43 Million - $9.34 Million
-1,545,924 Reduced 62.02%
946,792 $4.46 Million
Q4 2017

Feb 14, 2018

SELL
$3.26 - $4.78 $2.22 Million - $3.25 Million
-680,583 Reduced 21.45%
2,492,716 $8.13 Million
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $11 Million - $14.1 Million
3,173,299
3,173,299 $14 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.